Day Two - ET (Eastern Time, GMT-05:00)
Day Two - ET (Eastern Time, GMT-05:00)
Solution Summit: Unveiling the Future of Gross-to-Net: The Digital Innovation of Strategic Finance
- Shiraz Hasan - General Manager -Gross to Net Solutions, IQVIA
- John Lewis - Sr. Director Product Strategy, IQVIA
- Matt Champion - Assoc. Director Product Strategy, IQVIA
- Russell Bunch - Assoc. Director Product Strategy, IQVIA
- Jennifer Sharpe - Vice President, Gross-to-Net Consulting and Facilitator, Revenue Analytics Collaborative, IntegriChain
Valuable insight from seasoned thought leaders on how to roll out GTN management systems successfully and maximize commercial value for external stakeholders. This discussion will also explore how effective leadership combined with cross functional collaboration can drive financial success.
- Timothy Kocses - Executive Director, US Pharmaceuticals Finance Controller, Bristol Myers Squibb
- Joe Willadsen - Sr. Finance Director, Head Gross to Net, GSK
- Darpan Jhaveri - Senior Director - US Revenue and Inventory Accounting, Insmed Incorporated
- Kevin Nee - VP of Finance, Collegium Pharmaceutical, Inc.
- Ranish Singhvi - Vice President, Finance, Accord Healthcare
How does the collective healthcare community drive value through this dynamic ecosystem?
How can this value have a significant, positive impact on patient care?
Leveraging the remarkable technological advancements in data management, blockchain and AI, we can streamline the complexity of data, aligning how we define and transact through our sales and distribution chains. This alignment has a direct correlation to increased revenue and reduced cost, maximizing profitability for manufacturers, distributors, GPO's, IDN and care providers. Let us show you how blockchain can be used to reduce this dynamic complexity maximizing your return on investment while promoting increased value in patient care.
- Hilary Sherman - Director of Value Impact Analysis, Chronicled
- Neel Shah - Director, RSM US
- Designing processes to support effective communication, cross functional collaboration reporting and decision-making around GTN
- Looking at suitability of different governance models
- Use of technology in promoting greater transparency, accuracy and efficiency
- Neel Shah - Director, RSM US
- Nick Olivares - Controller, Lundbeck
- Kevin Nee - VP of Finance, Collegium Pharmaceutical, Inc.
- Prakash Chainani - Vice President – Finance, HR & IT, Lifestar Pharma LLC (a Mankind Group Company)
- Troy Kukorlo - Sr. Manager, Pricing - US Commercial, CSL Behring
- Darpan Jhaveri - Senior Director - US Revenue and Inventory Accounting, Insmed Incorporated
- Patrick Coyle - Former Vice President & CFO, Eisai Inc.
- Key considerations for planning GTN accruals and modeling pre-launch
- Strategies for team collaboration and engaging the right stakeholders
- Best practices for future forecasting of GTN for product launches, post-launch accrual analysis and adjustments
- Ensuring operational readiness to support contracting, pricing and product
- Patrick Coyle - Former Vice President & CFO, Eisai Inc.
- Patrick Park - Executive Director, Insights & Analytics, Regeneron
- Daniel Ryan - Director, Commercial Finance, Karyopharm Therapeutics Inc
- Angelina Pigna - Senior Director, Commercial Accounting, Mirati Therapeutics
- Bal Ram - VP Finance, US Operations, Indivior
- Lisa Mostovoy - SVP, Next Gen Commercialization, Population Health Partners
- Kent Rogers - Former SVP, Chief Industry Relations Officer, OptumRx
- Helen Sherman - Chief of Transformation, Evio
- Responding to regulatory pressures, payer price sensitivity and broader macroeconomic conditions
- Careful balancing act: ensuring affordable access for patients whilst protecting margins
- Understanding and navigating the complex network of pharma companies, payers, PBMs, healthcare providers and patients
- Vanessa Mirsky - Advisor, PharmaCCX
- Brandon Rawding - Finance Director, Market Access, DDR, AstraZeneca
- Rosalind Davis - Director, Government Pricing and Contracts, CSL Vifor
- Edward McAdam - Director, Government Pricing, Contracting Operations & Analytics, Indivior
- John Baker, Independent Expert
- Organizational alignment of roles and responsibilities — Market access, contracting, pricing, sales operations, finance, commercial
- Revenue analytics and forecasting standards — Overview of the variety of data, tools, methodologies and documentation
- Exploring the suitability of processes and solutions for small, mid, and large life science companies
- Matt Cullen - Vice President-Value and Access, Lexicon Pharmaceuticals
- Jordan Chavis - Senior Director, US Finance G2N Business Analysis, Lilly USA
- Nikita Mody-Patel - Head, Value, Access and Policy, Apellis Pharmaceuticals
- Bal Ram - VP Finance, US Operations, Indivior
- Amy Ramazio - Contract Forecasting & Analytics Director, GSK US Market Access
- Jennifer Sharpe - Vice President, Gross-to-Net Consulting and Facilitator, Revenue Analytics Collaborative, IntegriChain